[Necessity of glucose for long term blockade of the lipolysis with 3,5-dimethylisoxazole and 5-methylpyrazole-3-carboxylic acid].
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D000431:Ethanol / Q000494:pharmacology; D005227:Fatty Acids / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005234:Fatty Liver / Q000097:blood / Q000139:chemically induced / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D005990:Glycerol / Q000097:blood; D007275:Injections, Intravenous; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D010080:Oxazoles / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats
D001786:Blood Glucose; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010080:Oxazoles; D011720:Pyrazoles; D000431:Ethanol; D005947:Glucose; D005990:Glycerol
Notwendigkeit von Glucose zur Langzeitblockierung der Lipolyse mit 3,5-Dimethylisoxazol und 5-Methylpyrazol-3-Carbonsäure.